pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. And in 2023, these investments will hopefully pay off.

Marketing 92

Marketing Sales Medical Patients 92

PM360

DECEMBER 14, 2023

In total, 56 innovations were selected by PM360’s editorial staff for inclusion in the issue out of hundreds of submissions. Profiles of each of the selected innovations can be found online at [link] , or in PM360’s December print issue.

Insurance 64

Insurance Marketing Healthcare Healthcare 64

PM360

JUNE 26, 2023

Think about Simon, the big mall real estate company. If you run Veeva Crossix, Swoop, or first-party segments built in-house using your own data, you can layer this across all your campaigns, apart from Google. Media.Monks uses a good analogy to describe programmatic—it’s the mall. Ahh, the nostalgia. I miss those days. Your audiences!

Media 95

Media Marketing Pharma Sales 95

PM360

NOVEMBER 12, 2023

For the fourth year in a row artificial intelligence (AI) and Big Data ranked as the most impactful technologies in the industry, according to GlobalData’s “The State of the Biopharmaceutical Industry – 2023” report, which includes feedback from 198 companies. On top of that, the life sciences analytic market is expected to surpass $45.1

Marketing 59

Marketing Media Patients Healthcare 59

PM360

SEPTEMBER 15, 2022

Eric Solis, PhD of Takeda Pharmaceuticals and Mark Schulman of Veeva Crossix recently defined patient segments whose health behaviors were most affected by COVID using anonymized health and consumer data points across 300 million U.S. In other words, nearly everyone. patients and big data sources. Strategies to Support Patients Who Need Care.

Patients 59

Patients Pharma Healthcare Healthcare 59